Two Penguins Investment Pty Ltd

Loading…

Skip to main content

Home News Stories About FinTech (Future)

News / Story

Novo stock falls as much as 7% despite $23 billion sales target for blockbuster obesity drugs

Original reporting

Novo stock falls as much as 7% despite $23 billion sales target for blockbuster obesity drugs ↗
CNBC Top News · Published Sep 21, 2026

Two Penguins Investment Pty LtdAustralia

Publisher and interview content belongs to its respective source.PrivacyTerms